BOREA, Pier Andrea
 Distribuzione geografica
Continente #
NA - Nord America 35.988
EU - Europa 12.478
AS - Asia 8.523
SA - Sud America 33
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 24
AF - Africa 10
Totale 57.082
Nazione #
US - Stati Uniti d'America 35.899
CN - Cina 4.286
UA - Ucraina 2.961
IT - Italia 2.813
DE - Germania 2.573
TR - Turchia 2.186
SG - Singapore 1.672
GB - Regno Unito 1.235
SE - Svezia 1.052
FI - Finlandia 702
RU - Federazione Russa 275
PL - Polonia 259
FR - Francia 205
BE - Belgio 116
HK - Hong Kong 106
NL - Olanda 86
CA - Canada 83
ID - Indonesia 82
CZ - Repubblica Ceca 67
VN - Vietnam 48
IN - India 41
IR - Iran 33
LT - Lituania 30
ES - Italia 23
AU - Australia 21
EU - Europa 21
JP - Giappone 14
KR - Corea 14
CL - Cile 13
RO - Romania 13
AT - Austria 12
IE - Irlanda 11
BR - Brasile 10
IL - Israele 8
AR - Argentina 7
PT - Portogallo 7
TW - Taiwan 7
CH - Svizzera 6
GR - Grecia 5
MY - Malesia 5
NZ - Nuova Zelanda 5
HR - Croazia 4
HU - Ungheria 4
MX - Messico 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BD - Bangladesh 3
BG - Bulgaria 3
DZ - Algeria 3
EG - Egitto 3
IM - Isola di Man 3
MA - Marocco 3
NO - Norvegia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
DK - Danimarca 2
IQ - Iraq 2
JO - Giordania 2
LB - Libano 2
MD - Moldavia 2
PH - Filippine 2
PS - Palestinian Territory 2
SI - Slovenia 2
BO - Bolivia 1
CO - Colombia 1
EC - Ecuador 1
KH - Cambogia 1
MC - Monaco 1
ME - Montenegro 1
NI - Nicaragua 1
NP - Nepal 1
PK - Pakistan 1
SA - Arabia Saudita 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 57.082
Città #
Woodbridge 4.579
Fairfield 3.672
Jacksonville 3.290
Chandler 2.908
Houston 2.826
Ann Arbor 2.404
Ashburn 2.063
Wilmington 1.651
Seattle 1.514
Singapore 1.284
Santa Clara 1.281
Cambridge 1.157
Izmir 1.118
Nanjing 1.015
Beijing 714
Princeton 711
Boardman 520
Ferrara 422
Milan 383
San Diego 344
Nanchang 323
Shenyang 303
Shanghai 300
Los Angeles 244
Warsaw 236
Hebei 204
Dearborn 203
Bremen 182
San Mateo 176
Changsha 174
Tianjin 173
Addison 170
Jiaxing 167
New York 164
Jinan 120
Falls Church 115
Brussels 114
Hong Kong 103
Zhengzhou 102
Kunming 95
Auburn Hills 94
Norwalk 92
London 88
Mountain View 85
Jakarta 81
Ningbo 78
Helsinki 73
Rome 73
Munich 71
Philadelphia 70
Guangzhou 64
Orange 63
Redwood City 63
Florence 61
Düsseldorf 60
Verona 52
Des Moines 51
Dong Ket 46
Washington 44
Toronto 41
Augusta 40
Lanzhou 39
Taizhou 39
Frankfurt am Main 38
Brno 37
Indiana 37
Tappahannock 36
Amsterdam 34
Bologna 33
Chicago 30
Hangzhou 28
Redmond 27
Haikou 24
Naples 23
Torino 23
Olomouc 22
Ardabil 21
Bari 21
Hefei 21
Ottawa 21
Kilburn 20
Napoli 20
Leawood 16
Padova 16
San Francisco 15
Camerino 14
Catania 14
Cagliari 13
Espoo 13
Changchun 12
Ferrara di Monte Baldo 12
Taiyuan 12
Turin 12
Aversa 11
Monmouth Junction 11
Parma 10
Corvallis 9
Dublin 9
Fuzhou 9
Meppel 9
Totale 39.725
Nome #
Farmacologia cellulare e molecolare, sistemi di trasmissione e autacoidi. Trasmissione purinergica 1.171
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 339
Progetto ex 60%- I recettori dell’adenosina come possibili “biomarkers” dei tumori colorettali. Studio su tessuti umani sani e tumorali e sulle cellule del sangue periferico. 260
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 236
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 201
A glance at adenosine receptors: Novel target for antitumor therapy 200
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 196
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 168
The A3 adenosine receptor: history and perspectives 166
Pharmacology of Adenosine Receptors: The State of the Art 164
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 160
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 158
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 157
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 155
Recettori e trasduzione del segnale 155
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 154
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 151
2 Aralkynyl and 2-heteroalkynyl derivatives of adenosine 5'-N-ethyluronamide as selective A2A adenosine receptor agonists 149
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 149
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 149
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 149
Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts 146
History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents 146
Adenosine receptors and human melanoma 145
Pathological overproduction: the bad side of adenosine 145
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 144
Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors 144
Adenosine receptor targeting in health and disease 142
Current status of A1 adenosine receptor allosteric enhancers 142
Adenosine A1 receptors in the rat brain in the kindling model of epilepsy 142
Novel role for polycystin-1 in modulating cell proliferation through calcium oscillations in kidney cells. 140
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 140
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 140
7-Chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine (medazepam) 139
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 138
Receptor binding at two different temperatures to discriminate agonist and antagonist behaviour of adenosine A1 receptor ligands in rat brain 137
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 136
Octadecyl, phenyl and cyano phases comparison for the RP-HPLC prediction of octanol-water partition coefficient 135
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 135
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 135
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 135
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 135
Synthesis of a new series of pyrazolo[1,5-a]pyrimidines structurally related to zaleplon 134
Therapeutic potential of adenosine receptor antagonists and agonists 134
A(2A) adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients 132
Recettori e trasduzione del segnale 131
Comparison of Prazosin, Terazosin and Tamsulosin: Functional and Binding Studies in Isolated Prostatic and Vascular Human Tissues. 131
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 131
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 131
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 130
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 130
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 130
Effects of selective A1 and A2 adenosine receptor agonists on cardiovascular tissues 129
6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors 129
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation 129
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 129
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4- arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. Effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor 129
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 128
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 128
Pyrazolo [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine template: Organic and medicinal chemistry approach 128
Ala scan analogues of HOE 140. Synthesis and biological activities 127
Adenosine receptors and cancer 127
A Consensus Panel Review of Central Nervous System Effects of the Exposure to Low-Intensity Extremely Low-Frequency Magnetic Fields 127
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity 127
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 127
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 127
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes. 127
Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells 127
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 126
Opioid agonists and antagonists. Peptides containing N-terminal allyl groups and/or a thiomethylene linkage in place of a peptide bond 125
null 125
Temperature dependence of [3H]PAF binding to washed human platelets 124
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 124
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 124
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 124
A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release 124
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 124
Adenosine signaling contributes to ethanol-induced fatty liver in mice 123
Binding thermodynamics at A1 and A2A adenosine receptors 123
P2X1 and P2X3 Purinergic Receptors Differentially Modulate the Inflammatory Response in Human Osteoarthritic Synovial Fibroblasts 123
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 123
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 122
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 122
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 122
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 122
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 122
F638 a nitric oxide (NO)-donating gabapentin, NCX 1236, reverses the development of mechanical allodynia in streptozotocin-treated diabetic mice. 122
null 121
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour. 120
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 120
A convenient synthesis by microwave heating and pharmacological evaluation of novel benzoyltriazole and saccharine derivatives as 5-HT(1A) receptor ligands 120
Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E(2) and cytokine release in human osteoarthritic synovial fibroblasts 120
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields. 119
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension 119
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N- (substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor 119
Cholesterol esters of the liver, of the plasma and of the lipoproteins of rats poisoned with CCl4 118
Synthesis, radiolabeling, and preliminary biological evaluation of [H-3]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl )-piperazine, a potent antagonist radioligand for the P2X(7) receptor 118
Biochemical characterization of A1 adenosine receptors: experimental evaluation of their binding and intrinsic activity parameters 118
null 118
Medicinal chemistry, pharmacology, and potential therapeutic benefits of cannabinoid CB2receptor agonists 118
Totale 14.979
Categoria #
all - tutte 246.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 9.528
Totale 256.298


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.217 0 0 0 0 559 1.192 807 1.035 661 1.296 499 168
2020/20217.905 757 776 288 923 354 860 233 937 154 1.054 1.109 460
2021/20226.405 141 667 443 343 406 252 229 321 245 500 823 2.035
2022/20236.799 720 418 200 898 1.133 1.042 273 566 876 53 372 248
2023/20243.370 354 442 175 97 353 386 183 242 66 101 107 864
2024/20254.001 395 383 1.062 633 1.528 0 0 0 0 0 0 0
Totale 57.706